IDEAS home Printed from https://ideas.repec.org/f/c/pli1242.html
   My authors  Follow this author

Ethan M.J. Lieber

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Working papers

  1. Colleen Carey & Ethan M.J. Lieber & Sarah Miller, 2020. "Drug Firms' Payments and Physicians' Prescribing Behavior in Medicare Part D," NBER Working Papers 26751, National Bureau of Economic Research, Inc.

    Cited by:

    1. Jeffrey Clemens & Joshua D. Gottlieb & Jeffrey Hicks, 2020. "How Would Medicare for All Affect Health System Capacity? Evidence from Medicare for Some," NBER Working Papers 28062, National Bureau of Economic Research, Inc.
    2. Honda, Jun & Inderst, Roman & Ottaviani, Marco, 2022. "When Liability is Not Enough: Regulating Bonus Payments in Markets With Advice," EconStor Preprints 259401, ZBW - Leibniz Information Centre for Economics.
    3. Lawler, Emily C. & Skira, Meghan M., 2022. "Information shocks and pharmaceutical firms’ marketing efforts: Evidence from the Chantix black box warning removal," Journal of Health Economics, Elsevier, vol. 81(C).
    4. Leila Agha & Dan Zeltzer, 2019. "Drug Diffusion Through Peer Networks: The Influence of Industry Payments," NBER Working Papers 26338, National Bureau of Economic Research, Inc.
    5. Amaral-Garcia, S.;, 2022. "Medical Device Companies and Doctors: Do their interactions affect medical treatments?," Health, Econometrics and Data Group (HEDG) Working Papers 22/10, HEDG, c/o Department of Economics, University of York.
    6. Svetlana Beilfuss & Sebastian Linde, 2021. "Pharmaceutical opioid marketing and physician prescribing behavior," Health Economics, John Wiley & Sons, Ltd., vol. 30(12), pages 3159-3185, December.
    7. Elina Jussila & Kaisa Kotakorpi & Jouko Verho, 2022. "Prescription behavior of physicians in the public and private sector," Working Papers 5, Finnish Centre of Excellence in Tax Systems Research.
    8. Sofia Amaral-Garcia, 2020. "Medical Device Companies and Doctors: Do their Interactions Affect Medical Treatments ?," Working Papers ECARES 2020-18, ULB -- Universite Libre de Bruxelles.
    9. Thuy D. Nguyen & W. David Bradford & Kosali I. Simon, 2019. "How do Opioid Prescribing Restrictions Affect Pharmaceutical Promotion? Lessons from the Mandatory Access Prescription Drug Monitoring Programs," NBER Working Papers 26356, National Bureau of Economic Research, Inc.
    10. Joshua L. Krieger & Xuelin Li & Richard T. Thakor, 2022. "Find and Replace: R&D Investment Following the Erosion of Existing Products," Management Science, INFORMS, vol. 68(9), pages 6552-6571, September.
    11. Kelli Marquardt & Conor Ryan, 2023. "The Role of Information in Pharmaceutical Advertising: Theory and Evidence," Working Paper Series WP 2023-40, Federal Reserve Bank of Chicago.

  2. Kasey Buckles & William N. Evans & Ethan M.J. Lieber, 2020. "The Drug Crisis and the Living Arrangements of Children," NBER Working Papers 27633, National Bureau of Economic Research, Inc.

    Cited by:

    1. Cohle, Zachary & Ortega, Alberto, 2023. "The effect of the opioid crisis on patenting," Journal of Economic Behavior & Organization, Elsevier, vol. 214(C), pages 493-521.
    2. Robert Bifulco & Iuliia Shybalkina, 2022. "Fiscal Impacts of the Opioid Crisis on State and Local Governments," The ANNALS of the American Academy of Political and Social Science, , vol. 703(1), pages 324-349, September.
    3. Sim, Yongbo, 2023. "The effect of opioids on crime: Evidence from the introduction of OxyContin," International Review of Law and Economics, Elsevier, vol. 74(C).
    4. Grimon, Marie-Pascale, 2023. "Effects of the Child Protection System on Parents," Working Paper Series 2/2023, Stockholm University, Swedish Institute for Social Research.
    5. Kristin F. Butcher & Lucie Schmidt & Lara Shore‐Sheppard & Tara Watson, 2023. "Living with children and food insecurity in seniors," Applied Economic Perspectives and Policy, John Wiley & Sons, vol. 45(1), pages 234-261, March.
    6. Kaestner, Robert & Ziedan, Engy, 2023. "Effects of prescription opioids on employment, earnings, marriage, disability and mortality: Evidence from state opioid control policies," Labour Economics, Elsevier, vol. 82(C).
    7. Carolina Arteaga Cabrales & Victoria Barone, 2021. "The Opioid Epidemic: Causes and Consequences," Working Papers tecipa-698, University of Toronto, Department of Economics.
    8. Cotti, Chad D. & Gordanier, John M. & Ozturk, Orgul D., 2020. "The relationship of opioid prescriptions and the educational performance of children," Social Science & Medicine, Elsevier, vol. 265(C).
    9. Jessica Pac & Christine Durrance & Lawrence Berger & Deborah B. Ehrenthal, 2022. "The Effects of Opioid Use during Pregnancy on Infant Health and Well-Being," The ANNALS of the American Academy of Political and Social Science, , vol. 703(1), pages 106-138, September.
    10. Lindsey Rose Bullinger & Vivian Wang & Kenneth A. Feder, 2022. "Effects of Opioid Treatment Programs on Child Well-Being," The ANNALS of the American Academy of Political and Social Science, , vol. 703(1), pages 79-105, September.

  3. Abby E. Alpert & William N. Evans & Ethan M.J. Lieber & David Powell, 2019. "Origins of the Opioid Crisis and Its Enduring Impacts," NBER Working Papers 26500, National Bureau of Economic Research, Inc.

    Cited by:

    1. Chowdhury, Sulin, 2023. "Prescription Limiting Laws Effects on Opioid Misuse in the United States," 2023 Annual Meeting, July 23-25, Washington D.C. 335457, Agricultural and Applied Economics Association.
    2. Carey, Colleen & Lieber, Ethan M.J. & Miller, Sarah, 2021. "Drug firms’ payments and physicians’ prescribing behavior in Medicare Part D," Journal of Public Economics, Elsevier, vol. 197(C).
    3. Janet Currie & Hannes Schwandt, 2021. "The Opioid Epidemic Was Not Caused by Economic Distress but by Factors That Could Be More Rapidly Addressed," The ANNALS of the American Academy of Political and Social Science, , vol. 695(1), pages 276-291, May.
    4. Simone Balestra & Helge Liebert & Nicole Maestas & Tisamarie B. Sherry, 2022. "Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic," CESifo Working Paper Series 9704, CESifo.
    5. Abouk, Rahi & Powell, David, 2021. "Can electronic prescribing mandates reduce opioid-related overdoses?," Economics & Human Biology, Elsevier, vol. 42(C).
    6. Janet Currie & Hannes Schwandt, 2020. "The Opioid Epidemic Was Not Primarily Caused by Economic Distress But by Other Factors that Can be More Readily Addressed," Working Papers 2020-25, Princeton University. Economics Department..
    7. Janssen, Aljoscha & Zhang, Xuan, 2020. "Retail Pharmacies and Drug Diversion during the Opioid Epidemic," Working Paper Series 1373, Research Institute of Industrial Economics.
    8. David Powell & Rosalie Liccardo Pacula, 2020. "The Evolving Consequences of OxyContin Reformulation on Drug Overdoses," NBER Working Papers 26988, National Bureau of Economic Research, Inc.
    9. Lawler, Emily C. & Skira, Meghan M., 2022. "Information shocks and pharmaceutical firms’ marketing efforts: Evidence from the Chantix black box warning removal," Journal of Health Economics, Elsevier, vol. 81(C).
    10. Deiana, Claudio & Giua, Ludovica & Nistico, Roberto, 2019. "The Economics behind the Epidemic: Afghan Opium Price and Prescription Opioids in the US," IZA Discussion Papers 12872, Institute of Labor Economics (IZA).
    11. Sujeong Park & David Powell, 2020. "Is the Rise in Illicit Opioids Affecting Labor Supply and Disability Claiming Rates?," NBER Working Papers 27804, National Bureau of Economic Research, Inc.
    12. David M. Cutler & Edward L. Glaeser, 2021. "When Innovation Goes Wrong: Technological Regress and the Opioid Epidemic," Journal of Economic Perspectives, American Economic Association, vol. 35(4), pages 171-196, Fall.
    13. Melissa Newham & Marica Valente, 2022. "The Cost of Influence: How Gifts to Physicians Shape Prescriptions and Drug Costs," Papers 2203.01778, arXiv.org, revised Apr 2023.
    14. Walter D’Lima & Mark Thibodeau, 2023. "Health Crisis and Housing Market Effects - Evidence from the U.S. Opioid Epidemic," The Journal of Real Estate Finance and Economics, Springer, vol. 67(4), pages 735-752, November.
    15. David Cho & Daniel I. García & Joshua Montes & Alison E. Weingarden, 2021. "Labor Market Effects of the Oxycodone-Heroin Epidemic," Finance and Economics Discussion Series 2021-025, Board of Governors of the Federal Reserve System (U.S.).
    16. Shannon M. Monnat, 2022. "Demographic and Geographic Variation in Fatal Drug Overdoses in the United States, 1999–2020," The ANNALS of the American Academy of Political and Social Science, , vol. 703(1), pages 50-78, September.
    17. Boslett, Andrew & Hill, Elaine, 2022. "Mortality during resource booms and busts," Journal of Environmental Economics and Management, Elsevier, vol. 115(C).
    18. David Cho & Alvaro Mezza & Joshua Montes, 2022. "Choices and Implications when Measuring the Local Supply of Prescription Opioids," Finance and Economics Discussion Series 2022-078, Board of Governors of the Federal Reserve System (U.S.).
    19. Carolina Arteaga Cabrales & Victoria Barone, 2021. "The Opioid Epidemic: Causes and Consequences," Working Papers tecipa-698, University of Toronto, Department of Economics.
    20. Cotti, Chad D. & Gordanier, John M. & Ozturk, Orgul D., 2020. "The relationship of opioid prescriptions and the educational performance of children," Social Science & Medicine, Elsevier, vol. 265(C).
    21. Deiana, C. & Giua, L. & Nisticò, R., 2020. "Opium Price Shocks and Prescription Opioids in the US," Health, Econometrics and Data Group (HEDG) Working Papers 20/23, HEDG, c/o Department of Economics, University of York.
    22. Madsen, Jonas Krogh & Mikkelsen, Kim Sass & Moynihan, Donald, 2020. "Burdens, Sludge, Ordeals, Red Tape, Oh My! A User’s Guide to the Study of Frictions," SocArXiv qfykb, Center for Open Science.
    23. Thomas Lebesmuehlbacher & Rhet A. Smith, 2021. "The effect of medical cannabis laws on pharmaceutical marketing to physicians," Health Economics, John Wiley & Sons, Ltd., vol. 30(10), pages 2409-2436, September.

  4. William N. Evans & Ethan Lieber & Patrick Power, 2018. "How the Reformulation of OxyContin Ignited the Heroin Epidemic," NBER Working Papers 24475, National Bureau of Economic Research, Inc.

    Cited by:

    1. Christopher J. Ruhm, 2018. "Deaths of Despair or Drug Problems?," NBER Working Papers 24188, National Bureau of Economic Research, Inc.
    2. Molly Schnell & Janet Currie, 2017. "Addressing the Opioid Epidemic: Is There a Role for Physician Education?," NBER Working Papers 23645, National Bureau of Economic Research, Inc.
    3. Diwas KC & TI Tongil Kim & Jiayi Liu, 2022. "Electronic prescription monitoring and the opioid epidemic," Production and Operations Management, Production and Operations Management Society, vol. 31(11), pages 4057-4074, November.
    4. Pohl, R. Vincent, 2018. "Time Trends Matter: The Case of Medical Cannabis Laws and Opioid Overdose Mortality," MPRA Paper 88219, University Library of Munich, Germany.
    5. Christopher J. Ruhm, 2019. "Shackling the Identification Police?," Southern Economic Journal, John Wiley & Sons, vol. 85(4), pages 1016-1026, April.
    6. Alexander Ahammer, 2019. "A novel supply-side measure to combat abuse of addictive prescription drugs," Economics working papers 2019-11, Department of Economics, Johannes Kepler University Linz, Austria.
    7. Robert Bifulco & Iuliia Shybalkina, 2022. "Fiscal Impacts of the Opioid Crisis on State and Local Governments," The ANNALS of the American Academy of Political and Social Science, , vol. 703(1), pages 324-349, September.
    8. Johanna Catherine Maclean & Chandler McClellan & Michael F. Pesko & Daniel Polsky, 2023. "Medicaid reimbursement rates for primary care services and behavioral health outcomes," Health Economics, John Wiley & Sons, Ltd., vol. 32(4), pages 873-909, April.
    9. Janet Currie & Hannes Schwandt, 2021. "The Opioid Epidemic Was Not Caused by Economic Distress but by Factors That Could Be More Rapidly Addressed," The ANNALS of the American Academy of Political and Social Science, , vol. 695(1), pages 276-291, May.
    10. Simone Balestra & Helge Liebert & Nicole Maestas & Tisamarie B. Sherry, 2022. "Behavioral Responses to Supply-Side Drug Policy During the Opioid Epidemic," CESifo Working Paper Series 9704, CESifo.
    11. Aliprantis, Dionissi & Fee, Kyle & Schweitzer, Mark E., 2023. "Opioids and the labor market," Labour Economics, Elsevier, vol. 85(C).
    12. Claudio Deiana & Vikram Maheshri & Giovanni Mastrobuoni, 2020. "Migrants at Sea: Unintended Consequences of Search and Rescue Operations," Carlo Alberto Notebooks 636, Collegio Carlo Alberto.
    13. Alexander Ahammer & Martin Halla, 2022. "The intergenerational persistence of opioid dependence: Evidence from administrative data," Health Economics, John Wiley & Sons, Ltd., vol. 31(11), pages 2425-2444, November.
    14. Lindsey Rose Bullinger & Benjamin C. Ward, 2021. "What about the children? How opioid use affects child well‐being," Contemporary Economic Policy, Western Economic Association International, vol. 39(4), pages 737-759, October.
    15. Gihleb, Rania & Giuntella, Osea & Zhang, Ning, 2019. "Prescription Drug Monitoring Programs and Neonatal Outcomes," IZA Discussion Papers 12796, Institute of Labor Economics (IZA).
    16. Janet Currie & Hannes Schwandt, 2020. "The Opioid Epidemic Was Not Primarily Caused by Economic Distress But by Other Factors that Can be More Readily Addressed," Working Papers 2020-25, Princeton University. Economics Department..
    17. Janssen, Aljoscha & Zhang, Xuan, 2020. "Retail Pharmacies and Drug Diversion during the Opioid Epidemic," Working Paper Series 1373, Research Institute of Industrial Economics.
    18. Thomas C. Buchmueller & Colleen M. Carey & Giacomo Meille, 2019. "How Well Do Doctors Know Their Patients? Evidence from a Mandatory Access Prescription Drug Monitoring Program," NBER Working Papers 26159, National Bureau of Economic Research, Inc.
    19. David Powell & Rosalie Liccardo Pacula, 2020. "The Evolving Consequences of OxyContin Reformulation on Drug Overdoses," NBER Working Papers 26988, National Bureau of Economic Research, Inc.
    20. Bhashkar Mazumder, 2023. "The Effects of Prescription Drug Monitoring Programs on Labor Market Activity and Credit Outcomes," Working Paper Series WP 2023-13, Federal Reserve Bank of Chicago.
    21. Ruhm, Christopher J., 2019. "Drivers of the fatal drug epidemic," Journal of Health Economics, Elsevier, vol. 64(C), pages 25-42.
    22. Kasey Buckles & William N. Evans & Ethan M.J. Lieber, 2020. "The Drug Crisis and the Living Arrangements of Children," NBER Working Papers 27633, National Bureau of Economic Research, Inc.
    23. Deiana, Claudio & Giua, Ludovica & Nistico, Roberto, 2019. "The Economics behind the Epidemic: Afghan Opium Price and Prescription Opioids in the US," IZA Discussion Papers 12872, Institute of Labor Economics (IZA).
    24. Sauer, Jeffery & Stewart, Kathleen, 2023. "Geographic information science and the United States opioid overdose crisis: A scoping review of methods, scales, and application areas," Social Science & Medicine, Elsevier, vol. 317(C).
    25. Mark McInerney, 2019. "The Introduction of Abuse-Deterrent Opioids and Rates of Viral Infection," Working papers 2019-14, University of Connecticut, Department of Economics.
    26. Dhaval Dave & Monica Deza & Brady P. Horn, 2018. "Prescription Drug Monitoring Programs, Opioid Abuse, and Crime," NBER Working Papers 24975, National Bureau of Economic Research, Inc.
    27. Sujeong Park & David Powell, 2020. "Is the Rise in Illicit Opioids Affecting Labor Supply and Disability Claiming Rates?," NBER Working Papers 27804, National Bureau of Economic Research, Inc.
    28. Lucy Xiaolu Wang, 2021. "The complementarity of drug monitoring programs and health IT for reducing opioid‐related mortality and morbidity," Health Economics, John Wiley & Sons, Ltd., vol. 30(9), pages 2026-2046, September.
    29. David Beheshti, 2019. "Adverse health effects of abuse‐deterrent opioids: Evidence from the reformulation of OxyContin," Health Economics, John Wiley & Sons, Ltd., vol. 28(12), pages 1449-1461, December.
    30. Strulik, Holger, 2019. "Opioid epidemics," University of Göttingen Working Papers in Economics 371, University of Goettingen, Department of Economics.
    31. Johanna Catherine Maclean & Justine Mallatt & Christopher J. Ruhm & Kosali Simon, 2022. "The Opioid Crisis, Health, Healthcare, and Crime: A Review of Quasi-Experimental Economic Studies," The ANNALS of the American Academy of Political and Social Science, , vol. 703(1), pages 15-49, September.
    32. Daniele, Gianmarco & Le Moglie, Marco & Masera, Federico, 2023. "Pains, guns and moves: The effect of the U.S. opioid epidemic on Mexican migration," Journal of Development Economics, Elsevier, vol. 160(C).
    33. Casey B. Mulligan, 2020. "Prices and Federal Policies in Opioid Markets," Working Papers 2020-10, Becker Friedman Institute for Research In Economics.
    34. Doleac, Jennifer & Mukherjee, Anita, 2018. "The Moral Hazard of Lifesaving Innovations: Naloxone Access, Opioid Abuse, and Crime," IZA Discussion Papers 11489, Institute of Labor Economics (IZA).
    35. Casey B. Mulligan, 2022. "Lethal Unemployment Bonuses? Substitution and Income Effects on Substance Abuse, 2020-21," NBER Working Papers 29719, National Bureau of Economic Research, Inc.
    36. David Cho & Daniel I. García & Joshua Montes & Alison E. Weingarden, 2021. "Labor Market Effects of the Oxycodone-Heroin Epidemic," Finance and Economics Discussion Series 2021-025, Board of Governors of the Federal Reserve System (U.S.).
    37. Borgschulte, Mark & Corredor-Waldron, Adriana & Marshall, Guillermo, 2018. "A Path Out: Prescription Drug Abuse, Treatment, and Suicide," IZA Discussion Papers 11391, Institute of Labor Economics (IZA).
    38. Glei, Dana A. & Stokes, Andrew & Weinstein, Maxine, 2020. "Changes in mental health, pain, and drug misuse since the mid-1990s: Is there a link?," Social Science & Medicine, Elsevier, vol. 246(C).
    39. Dickson, Alex & Gehrsitz, Markus & Kemp, Jonathan, 2021. "Does a Spoonful of Sugar Levy Help the Calories Go Down? An Analysis of the UK Soft Drinks Industry Levy," IZA Discussion Papers 14528, Institute of Labor Economics (IZA).
    40. Roach, Travis & Nath, Saheli, 2023. "Counties with More Vietnam Veterans Have Higher Suicide Rates," Journal of Regional Analysis and Policy, Mid-Continent Regional Science Association, vol. 53(1), April.
    41. Dickson, Alex & Gehrsitz, Markus & Kemp, Jonathan, 2022. "Does a Spoonful of Sugar Levy Help the Calories Go Down? An Analysis of the UK Soft Drinks Industry Levy," VfS Annual Conference 2022 (Basel): Big Data in Economics 264048, Verein für Socialpolitik / German Economic Association.
    42. Strulik, Holger, 2019. "From pain patient to junkie: An economic theory of painkiller consumption and its impact on wellbeing and longevity," University of Göttingen Working Papers in Economics 359, University of Goettingen, Department of Economics, revised 2019.
    43. Boslett, Andrew & Hill, Elaine, 2022. "Mortality during resource booms and busts," Journal of Environmental Economics and Management, Elsevier, vol. 115(C).
    44. McGranahan, David & Parker, Timothy, 2021. "The Opioid Epidemic: A Geography in Two Phases," Economic Research Report 327197, United States Department of Agriculture, Economic Research Service.
    45. Ahammer, Alexander & Halla, Martin, 2020. "The Intergenerational Transmission of Opioid Dependence: Evidence from Administrative Data," IZA Discussion Papers 13395, Institute of Labor Economics (IZA).
    46. David Cho & Alvaro Mezza & Joshua Montes, 2022. "Choices and Implications when Measuring the Local Supply of Prescription Opioids," Finance and Economics Discussion Series 2022-078, Board of Governors of the Federal Reserve System (U.S.).
    47. Daniel W. Sacks & Alex Hollingsworth & Thuy D. Nguyen & Kosali I. Simon, 2019. "Can Policy Affect Initiation of Addictive Substance Use? Evidence from Opioid Prescribing," NBER Working Papers 25974, National Bureau of Economic Research, Inc.
    48. Cotti, Chad D. & Gordanier, John M. & Ozturk, Orgul D., 2020. "The relationship of opioid prescriptions and the educational performance of children," Social Science & Medicine, Elsevier, vol. 265(C).
    49. Thuy D. Nguyen & W. David Bradford & Kosali I. Simon, 2019. "How do Opioid Prescribing Restrictions Affect Pharmaceutical Promotion? Lessons from the Mandatory Access Prescription Drug Monitoring Programs," NBER Working Papers 26356, National Bureau of Economic Research, Inc.
    50. Shishir Shakya & Collin Hodges, 2023. "Must‐access prescription drug monitoring programs and retail opioid sales," Contemporary Economic Policy, Western Economic Association International, vol. 41(1), pages 146-165, January.
    51. Kim, Bokyung, 2021. "Must-access prescription drug monitoring programs and the opioid overdose epidemic: The unintended consequences," Journal of Health Economics, Elsevier, vol. 75(C).
    52. Casey B. Mulligan, 2021. "Peltzman Revisited: Quantifying 21st Century Opportunity Costs of FDA Regulation," NBER Working Papers 29574, National Bureau of Economic Research, Inc.
    53. Jessica Y. Ho, 2019. "The Contemporary American Drug Overdose Epidemic in International Perspective," Population and Development Review, The Population Council, Inc., vol. 45(1), pages 7-40, March.
    54. Dionissi Aliprantis & Mark E. Schweitzer, 2018. "Opioids and the Labor Market," Working Papers (Old Series) 1807, Federal Reserve Bank of Cleveland.
    55. Deiana, C. & Giua, L. & Nisticò, R., 2020. "Opium Price Shocks and Prescription Opioids in the US," Health, Econometrics and Data Group (HEDG) Working Papers 20/23, HEDG, c/o Department of Economics, University of York.
    56. Sumedha Gupta & Thuy D. Nguyen & Patricia R. Freeman & Kosali I. Simon, 2020. "Competitive Effects of Federal and State Opioid Restrictions: Evidence from the Controlled Substance Laws," NBER Working Papers 27520, National Bureau of Economic Research, Inc.
    57. Thomas C. Buchmueller & Colleen M. Carey & Giacomo Meille, 2020. "How well do doctors know their patients? Evidence from a mandatory access prescription drug monitoring program," Health Economics, John Wiley & Sons, Ltd., vol. 29(9), pages 957-974, September.
    58. Roach, Travis & Maisch, John & Pokharel, Suvechhya, 2020. "Bidding in Competition: Wholesale Alcohol Markups under Changing Liquor Laws," Journal of Regional Analysis and Policy, Mid-Continent Regional Science Association, vol. 50(1), September.
    59. Deiana, Claudio & Giua, Ludovica, 2018. "The US Opidemic: Prescription Opioids, Labour Market Conditions and Crime," MPRA Paper 85712, University Library of Munich, Germany.
    60. Colleen Heflin & Xiaohan Sun, 2022. "Food Insecurity and the Opioid Crisis," The ANNALS of the American Academy of Political and Social Science, , vol. 703(1), pages 262-284, September.
    61. Sumedha Gupta & Morhaf Al Achkar & Bradley Ray, 2022. "Are prescription drug monitoring laws effective for all? Evidence from administrative data," Contemporary Economic Policy, Western Economic Association International, vol. 40(1), pages 28-47, January.
    62. Shiyu Zhang & Daniel Guth, 2021. "The OxyContin Reformulation Revisited: New Evidence From Improved Definitions of Markets and Substitutes," Papers 2101.01128, arXiv.org, revised Jan 2021.
    63. Casey B. Mulligan, 2020. "Prices and Federal Policies in Opioid Markets," NBER Working Papers 26812, National Bureau of Economic Research, Inc.
    64. David M. Cutler & Edward L. Glaeser, 2021. "When Innovation Goes Wrong: Technological Regress and the Opioid Epidemic," NBER Working Papers 28873, National Bureau of Economic Research, Inc.

  5. Ethan M.J. Lieber & Lee M. Lockwood, 2018. "Targeting with In-kind Transfers: Evidence from Medicaid Home Care," NBER Working Papers 24267, National Bureau of Economic Research, Inc.

    Cited by:

    1. Norma B. Coe & Jing Guo & R. Tamara Konetzka & Courtney Harold Van Houtven, 2019. "What is the marginal benefit of payment‐induced family care? Impact on Medicaid spending and health of care recipients," Health Economics, John Wiley & Sons, Ltd., vol. 28(5), pages 678-692, May.
    2. Miller, Stephen M. & Neanidis, Kyriakos C., 2015. "Demographic transition and economic welfare: The role of in-cash and in-kind transfers," The Quarterly Review of Economics and Finance, Elsevier, vol. 58(C), pages 84-92.
    3. Abhijit Banerjee & Rema Hanna & Benjamin A Olken & Elan Satriawan & Sudarno Sumarto, "undated". "Food vs. Food Stamps: Evidence from an At-Scale Experiment in Indonesia," Working Papers 2373, Publications Department.
    4. Zeckhauser, Richard, 2021. "Strategic sorting: the role of ordeals in health care," Economics and Philosophy, Cambridge University Press, vol. 37(1), pages 64-81, March.
    5. Takanori Ida & Takunori Ishihara & Koichiro Ito & Daido Kido & Toru Kitagawa & Shosei Sakaguchi & Shusaku Sasaki, 2022. "Choosing Who Chooses: Selection-Driven Targeting in Energy Rebate Programs," NBER Working Papers 30469, National Bureau of Economic Research, Inc.
    6. Lucie Gadenne & Samuel Norris & Monica Singhal & Sandip Sukhtankar, 2021. "In-Kind Transfers as Insurance," NBER Working Papers 28507, National Bureau of Economic Research, Inc.
    7. Christian P R Schmid & Nicolas Schreiner & Alois Stutzer, 2022. "Transfer Payment Systems and Financial Distress: Insights from Health Insurance Premium Subsidies," Journal of the European Economic Association, European Economic Association, vol. 20(5), pages 1829-1858.
    8. Svetlana Pashchenko & Ponpoje Porapakkarm, 2019. "Reducing Medical Spending of the Publicly Insured: The Case for a Cash-out Option," American Economic Journal: Economic Policy, American Economic Association, vol. 11(3), pages 390-426, August.
    9. Jakub Grossmann & Filip Pertold & Michal Šoltés, 2023. "Parental Allowance Increase and Labor Supply: Evidence from a Czech Reform," CESifo Working Paper Series 10367, CESifo.
    10. Takanori Ida & Takunori Ishihara & Koichiro Ito & Daido Kido & Toru Kitagawa & Shosei Sakaguchi & Shusaku Sasaki, 2021. "Paternalism, Autonomy, or Both? Experimental Evidence from Energy Saving Programs," Papers 2112.09850, arXiv.org.
    11. Shang Wu & Hazel Bateman & Ralph Stevens & Susan Thorp, 2022. "Flexible insurance for long‐term care: A study of stated preferences," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 89(3), pages 823-858, September.
    12. de Bresser, Jochem & Knoef, Marike & van Ooijen, Raun, 2021. "Preferences for In-Kind and In-Cash Home Care Insurance," Discussion Paper 2021-033, Tilburg University, Center for Economic Research.
    13. de Bresser, Jochem & Knoef, Marike & van Ooijen, Raun, 2021. "Preferences for In-Kind and In-Cash Home Care Insurance," Other publications TiSEM fca83bd4-09cc-4072-81c6-0, Tilburg University, School of Economics and Management.
    14. Maria Polyakova & Stephen P. Ryan, 2019. "Subsidy Targeting with Market Power," NBER Working Papers 26367, National Bureau of Economic Research, Inc.
    15. Marta Lachowska & Isaac Sorkin & Stephen A. Woodbury, 2022. "Firms and Unemployment Insurance Take-up," NBER Working Papers 30266, National Bureau of Economic Research, Inc.
    16. Latha Thimmappa & Ashrita Saran & Sonia R. B. D'Souza & Binil V., 2021. "PROTOCOL: The effectiveness of social protection interventions in low‐ and middle‐income countries: An evidence and gap map," Campbell Systematic Reviews, John Wiley & Sons, vol. 17(3), September.
    17. Arapakis, K. & French, E. & Jones, J. & McCauley, J., 2022. "How should we fund end-of-life care in the USA?," Cambridge Working Papers in Economics 2249, Faculty of Economics, University of Cambridge.
    18. Campa, Pamela & Muehlenbachs, Lucija, 2021. "Addressing Environmental Justice through In-Kind Court Settlements," CEPR Discussion Papers 16293, C.E.P.R. Discussion Papers.
    19. de Bresser, Jochem & Knoef, Marike & van Ooijen, Raun, 2022. "Preferences for in-kind and in-cash home care insurance," Journal of Health Economics, Elsevier, vol. 84(C).
    20. Manasi Deshpande & Lee M. Lockwood, 2022. "Beyond Health: Nonhealth Risk and the Value of Disability Insurance," Econometrica, Econometric Society, vol. 90(4), pages 1781-1810, July.
    21. Amitabh Chandra & Courtney Coile & Corina Mommaerts, 2020. "What Can Economics Say About Alzheimer's Disease?," NBER Working Papers 27760, National Bureau of Economic Research, Inc.
    22. Diego Jimenez-Hernandez & Enrique Seira, 2022. "Should the government sell you goods? Evidence from the milk market in Mexico," Working Paper Series WP 2023-19, Federal Reserve Bank of Chicago.

  6. Steve Cicala & Ethan M.J. Lieber & Victoria Marone, 2017. "Cost of Service Regulation in U.S. Health Care: Minimum Medical Loss Ratios," NBER Working Papers 23353, National Bureau of Economic Research, Inc.

    Cited by:

    1. Tyrone T. Lin & Hui-Tzu Yen, 2020. "The Criteria of Optimal Training Cost Allocation for Sustainable Value in Aesthetic Medicine Industry," JRFM, MDPI, vol. 13(7), pages 1-18, July.
    2. Wu, Bingxiao, 2019. "Physician agency in China: Evidence from a drug-percentage incentive scheme," Journal of Development Economics, Elsevier, vol. 140(C), pages 72-89.
    3. Daniel W. Sacks & Khoa Vu & Tsan-Yao Huang & Pinar Karaca-Mandic, 2017. "How do insurance firms respond to financial risk sharing regulations? Evidence from the Affordable Care Act," NBER Working Papers 24129, National Bureau of Economic Research, Inc.
    4. Lieber, Ethan M.J., 2018. "Does health insurance coverage fall when nonprofit insurers become for-profits?," Journal of Health Economics, Elsevier, vol. 57(C), pages 75-88.

  7. Ethan M.J. Lieber & Lee M. Lockwood, 2013. "Costs and Benefits of In-Kind Transfers: The Case of Medicaid Home Care Benefits," Working Papers wp294, University of Michigan, Michigan Retirement Research Center.

    Cited by:

    1. Norma B. Coe & Jing Guo & R. Tamara Konetzka & Courtney Harold Van Houtven, 2019. "What is the marginal benefit of payment‐induced family care? Impact on Medicaid spending and health of care recipients," Health Economics, John Wiley & Sons, Ltd., vol. 28(5), pages 678-692, May.
    2. Miller, Stephen M. & Neanidis, Kyriakos C., 2015. "Demographic transition and economic welfare: The role of in-cash and in-kind transfers," The Quarterly Review of Economics and Finance, Elsevier, vol. 58(C), pages 84-92.
    3. Abhijit Banerjee & Rema Hanna & Benjamin A Olken & Elan Satriawan & Sudarno Sumarto, "undated". "Food vs. Food Stamps: Evidence from an At-Scale Experiment in Indonesia," Working Papers 2373, Publications Department.
    4. Zeckhauser, Richard, 2021. "Strategic sorting: the role of ordeals in health care," Economics and Philosophy, Cambridge University Press, vol. 37(1), pages 64-81, March.
    5. Takanori Ida & Takunori Ishihara & Koichiro Ito & Daido Kido & Toru Kitagawa & Shosei Sakaguchi & Shusaku Sasaki, 2022. "Choosing Who Chooses: Selection-Driven Targeting in Energy Rebate Programs," NBER Working Papers 30469, National Bureau of Economic Research, Inc.
    6. Lucie Gadenne & Samuel Norris & Monica Singhal & Sandip Sukhtankar, 2021. "In-Kind Transfers as Insurance," NBER Working Papers 28507, National Bureau of Economic Research, Inc.
    7. Christian P R Schmid & Nicolas Schreiner & Alois Stutzer, 2022. "Transfer Payment Systems and Financial Distress: Insights from Health Insurance Premium Subsidies," Journal of the European Economic Association, European Economic Association, vol. 20(5), pages 1829-1858.
    8. Svetlana Pashchenko & Ponpoje Porapakkarm, 2019. "Reducing Medical Spending of the Publicly Insured: The Case for a Cash-out Option," American Economic Journal: Economic Policy, American Economic Association, vol. 11(3), pages 390-426, August.
    9. Jakub Grossmann & Filip Pertold & Michal Šoltés, 2023. "Parental Allowance Increase and Labor Supply: Evidence from a Czech Reform," CESifo Working Paper Series 10367, CESifo.
    10. Takanori Ida & Takunori Ishihara & Koichiro Ito & Daido Kido & Toru Kitagawa & Shosei Sakaguchi & Shusaku Sasaki, 2021. "Paternalism, Autonomy, or Both? Experimental Evidence from Energy Saving Programs," Papers 2112.09850, arXiv.org.
    11. Shang Wu & Hazel Bateman & Ralph Stevens & Susan Thorp, 2022. "Flexible insurance for long‐term care: A study of stated preferences," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 89(3), pages 823-858, September.
    12. de Bresser, Jochem & Knoef, Marike & van Ooijen, Raun, 2021. "Preferences for In-Kind and In-Cash Home Care Insurance," Discussion Paper 2021-033, Tilburg University, Center for Economic Research.
    13. de Bresser, Jochem & Knoef, Marike & van Ooijen, Raun, 2021. "Preferences for In-Kind and In-Cash Home Care Insurance," Other publications TiSEM fca83bd4-09cc-4072-81c6-0, Tilburg University, School of Economics and Management.
    14. Maria Polyakova & Stephen P. Ryan, 2019. "Subsidy Targeting with Market Power," NBER Working Papers 26367, National Bureau of Economic Research, Inc.
    15. Marta Lachowska & Isaac Sorkin & Stephen A. Woodbury, 2022. "Firms and Unemployment Insurance Take-up," NBER Working Papers 30266, National Bureau of Economic Research, Inc.
    16. Latha Thimmappa & Ashrita Saran & Sonia R. B. D'Souza & Binil V., 2021. "PROTOCOL: The effectiveness of social protection interventions in low‐ and middle‐income countries: An evidence and gap map," Campbell Systematic Reviews, John Wiley & Sons, vol. 17(3), September.
    17. Arapakis, K. & French, E. & Jones, J. & McCauley, J., 2022. "How should we fund end-of-life care in the USA?," Cambridge Working Papers in Economics 2249, Faculty of Economics, University of Cambridge.
    18. Campa, Pamela & Muehlenbachs, Lucija, 2021. "Addressing Environmental Justice through In-Kind Court Settlements," CEPR Discussion Papers 16293, C.E.P.R. Discussion Papers.
    19. de Bresser, Jochem & Knoef, Marike & van Ooijen, Raun, 2022. "Preferences for in-kind and in-cash home care insurance," Journal of Health Economics, Elsevier, vol. 84(C).
    20. Manasi Deshpande & Lee M. Lockwood, 2022. "Beyond Health: Nonhealth Risk and the Value of Disability Insurance," Econometrica, Econometric Society, vol. 90(4), pages 1781-1810, July.
    21. Amitabh Chandra & Courtney Coile & Corina Mommaerts, 2020. "What Can Economics Say About Alzheimer's Disease?," NBER Working Papers 27760, National Bureau of Economic Research, Inc.
    22. Diego Jimenez-Hernandez & Enrique Seira, 2022. "Should the government sell you goods? Evidence from the milk market in Mexico," Working Paper Series WP 2023-19, Federal Reserve Bank of Chicago.

Articles

  1. Buckles, Kasey & Evans, William N. & Lieber, Ethan M.J., 2023. "The drug crisis and the living arrangements of children," Journal of Health Economics, Elsevier, vol. 87(C).
    See citations under working paper version above.
  2. Abby Alpert & William N Evans & Ethan M J Lieber & David Powell, 2023. "Origins of the Opioid Crisis and its Enduring Impacts," The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 137(2), pages 1139-1179.
    See citations under working paper version above.
  3. Carey, Colleen & Lieber, Ethan M.J. & Miller, Sarah, 2021. "Drug firms’ payments and physicians’ prescribing behavior in Medicare Part D," Journal of Public Economics, Elsevier, vol. 197(C).
    See citations under working paper version above.
  4. Ethan M. J. Lieber & Lee M. Lockwood, 2019. "Targeting with In-Kind Transfers: Evidence from Medicaid Home Care," American Economic Review, American Economic Association, vol. 109(4), pages 1461-1485, April.
    See citations under working paper version above.
  5. William N. Evans & Ethan M. J. Lieber & Patrick Power, 2019. "How the Reformulation of OxyContin Ignited the Heroin Epidemic," The Review of Economics and Statistics, MIT Press, vol. 101(1), pages 1-15, March.
    See citations under working paper version above.
  6. Steve Cicala & Ethan M. J. Lieber & Victoria Marone, 2019. "Regulating Markups in US Health Insurance," American Economic Journal: Applied Economics, American Economic Association, vol. 11(4), pages 71-104, October.

    Cited by:

    1. Patricia H. Born & E. Tice Sirmans & Petra Steinorth, 2023. "Health insurers' use of quality improvement expenses to achieve a minimum medical loss ratio requirement," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 90(1), pages 123-154, March.
    2. E. Tice Sirmans & Petra Steinorth, 2020. "New post‐ACA insurance data highlights health insurer spending on health care quality," Risk Management and Insurance Review, American Risk and Insurance Association, vol. 23(2), pages 209-218, June.
    3. Mark Shepard & Ethan Forsgren, 2023. "Do insurers respond to active purchasing? Evidence from the Massachusetts health insurance exchange," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 90(1), pages 9-31, March.
    4. Mohammed Al‐Hamdani & Kayla M. Joyce & Tristan Park & Megan E. Cowie & Sherry H. Stewart, 2021. "Cannabis packaging: An opportunity for facilitating informed decisions," Journal of Consumer Affairs, Wiley Blackwell, vol. 55(3), pages 1150-1168, September.
    5. Patricia H. Born & Evan M. Eastman & E. Tice Sirmans, 2023. "Managed care or carefully managed? Management of underwriting profitability by health insurers," The Geneva Papers on Risk and Insurance - Issues and Practice, Palgrave Macmillan;The Geneva Association, vol. 48(1), pages 5-31, January.
    6. Abe Dunn & Joshua D. Gottlieb & Adam Hale Shapiro & Daniel J. Sonnenstuhl & Pietro Tebaldi, 2023. "A Denial a Day Keeps the Doctor Away," Working Paper Series 2023-03, Federal Reserve Bank of San Francisco.
    7. Yu Lei & Mark J. Browne, 2020. "Health insurers' operations in the face of health care reform: An analysis of the Supplemental Health Care Exhibit," Risk Management and Insurance Review, American Risk and Insurance Association, vol. 23(3), pages 277-286, September.

  7. Lieber, Ethan M.J., 2018. "Does health insurance coverage fall when nonprofit insurers become for-profits?," Journal of Health Economics, Elsevier, vol. 57(C), pages 75-88.

    Cited by:

    1. Steve Cicala & Ethan M.J. Lieber & Victoria Marone, 2017. "Cost of Service Regulation in U.S. Health Care: Minimum Medical Loss Ratios," NBER Working Papers 23353, National Bureau of Economic Research, Inc.
    2. Steve Cicala & Ethan M. J. Lieber & Victoria Marone, 2019. "Regulating Markups in US Health Insurance," American Economic Journal: Applied Economics, American Economic Association, vol. 11(4), pages 71-104, October.

  8. Lieber, Ethan M.J. & Skimmyhorn, William, 2018. "Peer effects in financial decision-making," Journal of Public Economics, Elsevier, vol. 163(C), pages 37-59.

    Cited by:

    1. Huang, Lingbo & Xiao, Erte, 2021. "Peer effects in public support for Pigouvian taxation," Journal of Economic Behavior & Organization, Elsevier, vol. 187(C), pages 192-204.
    2. Andrieş, Alin Marius & Walker, Sarah, 2023. "When the message hurts: The unintended impacts of nudges on saving," Journal of Comparative Economics, Elsevier, vol. 51(2), pages 439-456.
    3. Goldin, Jacob & Homonoff, Tatiana & Patterson, Richard & Skimmyhorn, William, 2020. "How much to save? Decision costs and retirement plan participation," Journal of Public Economics, Elsevier, vol. 191(C).
    4. Jones, Todd R. & Kofoed, Michael S., 2020. "Do peers influence occupational preferences? Evidence from randomly-assigned peer groups at West Point," Journal of Public Economics, Elsevier, vol. 184(C).
    5. Rob Bauer & Inka Eberhardt & Paul Smeets, 2022. "A Fistful of Dollars: Financial Incentives, Peer Information, and Retirement Savings," The Review of Financial Studies, Society for Financial Studies, vol. 35(6), pages 2981-3020.
    6. Bing Han & David Hirshleifer & Johan Walden, 2023. "Visibility Bias in the Transmission of Consumption Beliefs and Undersaving," Journal of Finance, American Finance Association, vol. 78(3), pages 1647-1704, June.
    7. Chesney, Alexander J., 2022. "Should I get a master’s degree?," Economics of Education Review, Elsevier, vol. 91(C).
    8. Niels Vermeer & Maarten Rooij & Daniel Vuuren, 2019. "Retirement Age Preferences: The Role of Social Interactions and Anchoring at the Statutory Retirement Age," De Economist, Springer, vol. 167(4), pages 307-345, December.
    9. Lucks, Konstantin E. & Luhrmann, Melanie & Winter, Joachim, 2020. "Assortative matching and social interaction: A field experiment on adolescents' risky choices," Munich Reprints in Economics 84741, University of Munich, Department of Economics.
    10. Zhao, Chuanmin & Qu, Xi, 2021. "Peer effects in pension decision-making: evidence from China's new rural pension scheme," Labour Economics, Elsevier, vol. 69(C).
    11. Dur, Robert & Fleming, Dimitry & van Garderen, Marten & van Lent, Max, 2021. "A social norm nudge to save more: A field experiment at a retail bank," Journal of Public Economics, Elsevier, vol. 200(C).
    12. Francesco D'Acunto & Alberto G. Rossi & Michael Weber & Michael Weber, 2019. "Crowdsourcing financial information to change spending behavior," CESifo Working Paper Series 7533, CESifo.
    13. Grossmann, Max & Hackethal, Andreas & Laudi, Marten & Pauls, Thomas, 2023. "Conform to the norm. Peer information and sustainable investments," SAFE Working Paper Series 412, Leibniz Institute for Financial Research SAFE.
    14. Malvaso, Catia G. & Delfabbro, Paul H., 2020. "Description and evaluation of a trial program aimed at reunifying adolescents in statutory long-term out-of-home care with their birth families: The adolescent reunification program," Children and Youth Services Review, Elsevier, vol. 119(C).
    15. Srbinoski Bojan & Strozzi Fernanda & Poposki Klime & Born Patricia H., 2020. "Trends in Life Insurance Demand and Lapse Literature," Asia-Pacific Journal of Risk and Insurance, De Gruyter, vol. 14(2), pages 1-46, July.
    16. Hoffmann, Arvid O.I. & Plotkina, Daria, 2020. "Why and when does financial information affect retirement planning intentions and which consumers are more likely to act on them?," Journal of Business Research, Elsevier, vol. 117(C), pages 411-431.
    17. Sandro Ambuehl & B. Douglas Bernheim & Fulya Ersoy & Donna Harris, 2018. "Peer Advice on Financial Decisions: A case of the blind leading the blind?," NBER Working Papers 25034, National Bureau of Economic Research, Inc.
    18. Brian J. Miller & William L. Skimmyhorn, 2018. "I Want You! Expanding College Access through Targeted Recruiting Efforts," Education Finance and Policy, MIT Press, vol. 13(3), pages 395-418, Summer.
    19. Timothy F. Harris & Aaron Yelowitz & Jeffery Talbert & Alison Davis, 2023. "Adverse selection in the group life insurance market," Economic Inquiry, Western Economic Association International, vol. 61(4), pages 911-941, October.
    20. Guo, Juncong & Qu, Xi, 2022. "Competition in household human capital investments: Strength, motivations and consequences," Journal of Development Economics, Elsevier, vol. 158(C).

  9. Ethan M. J. Lieber, 2017. "Does It Pay to Know Prices in Health Care?," American Economic Journal: Economic Policy, American Economic Association, vol. 9(1), pages 154-179, February.

    Cited by:

    1. Rice, Thomas & Unruh, Lynn Y. & van Ginneken, Ewout & Rosenau, Pauline & Barnes, Andrew J., 2018. "Universal coverage reforms in the USA: From Obamacare through Trump," Health Policy, Elsevier, vol. 122(7), pages 698-702.
    2. Martin Gaynor & Kate Ho & Robert Town, 2014. "The Industrial Organization of Health Care Markets," NBER Working Papers 19800, National Bureau of Economic Research, Inc.
    3. Ericson, Keith Marzilli & Kircher, Philipp & Spinnewijn, Johannes & Starc, Amanda, 2015. "Inferring risk perceptions and preferences using choice from insurance menus: theory and evidence," LSE Research Online Documents on Economics 87780, London School of Economics and Political Science, LSE Library.
    4. Zhang, Angela & Prang, Khic-Houy & Devlin, Nancy & Scott, Anthony & Kelaher, Margaret, 2020. "The impact of price transparency on consumers and providers: A scoping review," Health Policy, Elsevier, vol. 124(8), pages 819-825.
    5. Katharina Knoll & Moritz Schularick & Thomas Steger, 2014. "No price like home: global house prices, 1870-2012," Globalization Institute Working Papers 208, Federal Reserve Bank of Dallas.
    6. Matthew Grennan & Ashley Swanson, 2020. "Transparency and Negotiated Prices: The Value of Information in Hospital-Supplier Bargaining," Journal of Political Economy, University of Chicago Press, vol. 128(4), pages 1234-1268.
    7. Sunday Stephen AJEMUNIGBOHUN & Sulaiman Ademola Oreshile, 2019. "Risk Aversion And Motor Insurance Demand: Empirical Evidence From Nigeria," Annals of University of Craiova - Economic Sciences Series, University of Craiova, Faculty of Economics and Business Administration, vol. 2(47), pages 211-222, December.
    8. Sebastian Linde & Ralph Siebert, 2021. "Exploring the Heterogeneous Effects of State Price Transparency Laws on Charge Prices, Negotiated Prices, and Operating Costs," CESifo Working Paper Series 9348, CESifo.
    9. Husiatyński, Maciej, 2021. "Three essays on individual behavior and new technologies," Other publications TiSEM 1a7d7036-3d54-4a7b-a425-e, Tilburg University, School of Economics and Management.
    10. Zarek C. Brot-Goldberg & Amitabh Chandra & Benjamin R. Handel & Jonathan T. Kolstad, 2017. "What does a Deductible Do? The Impact of Cost-Sharing on Health Care Prices, Quantities, and Spending Dynamics," The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 132(3), pages 1261-1318.
    11. Christopher Whaley & Timothy Brown & James Robinson, 2019. "Consumer Responses to Price Transparency Alone versus Price Transparency Combined with Reference Pricing," American Journal of Health Economics, MIT Press, vol. 5(2), pages 227-249, Spring.
    12. Stephenson Strobel, 2023. "Waiting for Dr. Godot: how much and who responds to predicted health care wait times?," Papers 2309.13219, arXiv.org.
    13. Zach Y. Brown, 2019. "Equilibrium Effects of Health Care Price Information," The Review of Economics and Statistics, MIT Press, vol. 101(4), pages 699-712, October.
    14. Haizhen Lin & Daniel W. Sacks, 2016. "Intertemporal Substitution in Health Care Demand: Evidence from the RAND Health Insurance Experiment," NBER Working Papers 22802, National Bureau of Economic Research, Inc.
    15. Lee, Chung-Ying, 2020. "Pricing strategy and moral hazard: Copay coupons in pharmaceuticals," International Journal of Industrial Organization, Elsevier, vol. 70(C).
    16. Lin, Haizhen & Sacks, Daniel W., 2019. "Intertemporal substitution in health care demand: Evidence from the RAND Health Insurance Experiment," Journal of Public Economics, Elsevier, vol. 175(C), pages 29-43.
    17. Chernew, Michael & Cooper, Zack & Hallock, Eugene Larsen & Scott Morton, Fiona, 2021. "Physician agency, consumerism, and the consumption of lower-limb MRI scans," Journal of Health Economics, Elsevier, vol. 76(C).
    18. Klein, Tobias & Husiatyński, Maciej & Mikkers, Misja, 2021. "Increasing price transparency in the Dutch health care market does not affect provider choice," CEPR Discussion Papers 15981, C.E.P.R. Discussion Papers.
    19. Lawrence C. Pellegrini & Kimberley H. Geissler, 2019. "Supplemental Security Income enrollment and health care and social assistance employment and wages," International Journal of Health Planning and Management, Wiley Blackwell, vol. 34(4), pages 1319-1332, October.

  10. Ethan M. J. Lieber, 2014. "Medical Malpractice Reform, the Supply of Physicians, and Adverse Selection," Journal of Law and Economics, University of Chicago Press, vol. 57(2), pages 501-527.

    Cited by:

    1. McMichael, Benjamin, 2017. "Beyond Physicians: The Effect of Licensing and Liability Laws on the Supply of Nurse Practitioners and Physician Assistants," Working Papers 07538, George Mason University, Mercatus Center.
    2. Ellyson, Alice M. & Robertson, Justin C., 2019. "Can malpractice pressure compel a physician to relocate?," International Review of Law and Economics, Elsevier, vol. 57(C), pages 37-48.
    3. Pinka Chatterji & Siyang Li & Gerald R. Marschke, 2018. "Malpractice Reform and the Sorting of New Physicians by Medical Human Capital," NBER Working Papers 24401, National Bureau of Economic Research, Inc.
    4. Charles L. Baum, 2020. "The effects of medical malpractice tort reform on physician supply an analysis of legislative changes from 2009 to 2016," Southern Economic Journal, John Wiley & Sons, vol. 87(2), pages 540-575, October.
    5. Javier Cano-Urbina & Daniel Montanera, 2017. "Do tort reforms impact the incidence of birth by cesarean section? A reassessment," International Journal of Health Economics and Management, Springer, vol. 17(1), pages 103-112, March.
    6. Hsueh-Hsiang Li & Alexandra Bernasek, 2018. "Tort Reforms and the Gender Distribution of Physicians," Eastern Economic Journal, Palgrave Macmillan;Eastern Economic Association, vol. 44(3), pages 437-454, June.
    7. Elissa P. Gentry & Benjamin J. McMichael, 2020. "Responses to Liability Immunization: Evidence from Medical Devices," Journal of Empirical Legal Studies, John Wiley & Sons, vol. 17(4), pages 789-819, December.
    8. Jingshu Luo & Hua Chen & Martin Grace, 2022. "Medicaid expansion, tort reforms, and medical liability costs," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 89(3), pages 789-821, September.
    9. Kitamura Miguel (Masaru) & Arai Koki, 2022. "Impact of Shorter Trial Periods in Medical Litigation," Asian Journal of Law and Economics, De Gruyter, vol. 13(3), pages 301-322, December.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.